BR112013029202A2 - solução farmacêutica, recipiente selado, inalador de dose medida, método para tratar um paciente que sofre ou que está susceptível a sofrer de um distúrbio respiratório, usos de um propelente, de uma composição farmacêutica, e, de um aparelho de administração de medicamentos que contém uma composição farmacêutica - Google Patents
solução farmacêutica, recipiente selado, inalador de dose medida, método para tratar um paciente que sofre ou que está susceptível a sofrer de um distúrbio respiratório, usos de um propelente, de uma composição farmacêutica, e, de um aparelho de administração de medicamentos que contém uma composição farmacêuticaInfo
- Publication number
- BR112013029202A2 BR112013029202A2 BR112013029202A BR112013029202A BR112013029202A2 BR 112013029202 A2 BR112013029202 A2 BR 112013029202A2 BR 112013029202 A BR112013029202 A BR 112013029202A BR 112013029202 A BR112013029202 A BR 112013029202A BR 112013029202 A2 BR112013029202 A2 BR 112013029202A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- propellant
- susceptible
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1108039.7A GB201108039D0 (en) | 2011-05-13 | 2011-05-13 | Compositions |
| GB1108039.7 | 2011-05-13 | ||
| PCT/GB2012/051059 WO2012156711A1 (en) | 2011-05-13 | 2012-05-11 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013029202A2 true BR112013029202A2 (pt) | 2017-02-14 |
| BR112013029202B1 BR112013029202B1 (pt) | 2022-04-12 |
Family
ID=44260493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013029202-4A BR112013029202B1 (pt) | 2011-05-13 | 2012-05-11 | Solução farmacêutica para administração usando um inalador de dose medida compreendendo dipropionato de beclometasona e/ou propionato de fluticasona, etanol e propelente de 1,1-difluoroetano, recipiente selado, inalador de dose medida, e, uso da composição |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20140234229A1 (pt) |
| EP (1) | EP2706987B8 (pt) |
| JP (2) | JP5904613B2 (pt) |
| CN (2) | CN103517706A (pt) |
| AU (1) | AU2012257546C1 (pt) |
| BR (1) | BR112013029202B1 (pt) |
| CA (1) | CA2835810C (pt) |
| ES (1) | ES2541417T3 (pt) |
| GB (1) | GB201108039D0 (pt) |
| MX (1) | MX340924B (pt) |
| WO (1) | WO2012156711A1 (pt) |
| ZA (1) | ZA201308208B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
| GB201306984D0 (en) | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
| GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| CA3007050C (en) * | 2015-12-04 | 2020-12-08 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition comprising a formoterol compound |
| GB2554092A (en) * | 2016-09-19 | 2018-03-28 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| CN105476961B (zh) * | 2015-12-16 | 2019-01-04 | 武汉同济现代医药科技股份有限公司 | 一种丙酸倍氯米松气雾剂及其制备方法 |
| JP6781832B2 (ja) * | 2016-09-19 | 2020-11-04 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 医薬組成物 |
| CN113288869A (zh) | 2016-09-19 | 2021-08-24 | 墨西哥氟石股份公司 | 药物组合物 |
| AU2017328910B2 (en) | 2016-09-19 | 2020-04-09 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| EP3922240B1 (en) * | 2016-09-19 | 2023-06-21 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition comprising tiotropium bromide |
| GB201620519D0 (en) * | 2016-12-02 | 2017-01-18 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| GB2554088A (en) * | 2016-09-19 | 2018-03-28 | Mexichem Fluor Sa De Cv | Pharmaceautical composition |
| GB2554091A (en) * | 2016-09-19 | 2018-03-28 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| ES2968453T3 (es) | 2016-09-19 | 2024-05-09 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende glicopirrolato |
| GB2558191A (en) * | 2016-09-19 | 2018-07-11 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| US11521518B1 (en) | 2017-05-04 | 2022-12-06 | IngMar Medical, Ltd. | Airway simulation system |
| GB201712159D0 (en) * | 2017-07-28 | 2017-09-13 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| CN112203649A (zh) * | 2018-06-07 | 2021-01-08 | 金德瓦药物控释有限公司 | 氟替卡松和维兰特罗制剂以及吸入器 |
| GB2584686A (en) | 2019-06-11 | 2020-12-16 | Mexichem Fluor Sa De Cv | Methods |
| JP2023511615A (ja) | 2020-01-28 | 2023-03-20 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 緩衝化医薬製剤を含む加圧定量吸入器 |
| US20230080276A1 (en) | 2020-02-20 | 2023-03-16 | Chiesi Farmaceutici S.P.A. | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
| US5439670A (en) | 1989-11-28 | 1995-08-08 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| IE67185B1 (en) | 1990-02-02 | 1996-03-06 | Fisons Plc | Propellant compositions |
| DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
| MX9203481A (es) * | 1990-10-18 | 1992-07-01 | Minnesota Mining & Mfg | Formulaciones. |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| MY131733A (en) | 1994-12-22 | 2007-08-30 | Astra Ab | Aerosol drug formulations |
| HU219899B (hu) * | 1995-04-14 | 2001-09-28 | Glaxo Wellcome Inc. | Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban |
| WO1998034595A1 (de) * | 1997-02-05 | 1998-08-13 | Jago Research Ag | Medizinische aerosolformulierungen |
| DE69814428T2 (de) * | 1997-09-29 | 2004-05-13 | Nektar Therapeutics, San Carlos | In verneblern verwendbare, stabilisierte zubereitungen |
| US6103266A (en) | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| ATE234604T1 (de) | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
| DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| WO2001019342A2 (en) * | 1999-09-11 | 2001-03-22 | Glaxo Group Limited | Pharmaceutical formulation of fluticasone propionate |
| GB2392915B (en) * | 1999-09-11 | 2004-04-28 | Glaxo Group Ltd | Pharmaceutical formulation of fluticasone propionate |
| US6432415B1 (en) * | 1999-12-17 | 2002-08-13 | Axrix Laboratories, Inc. | Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| CN1144582C (zh) | 2000-11-28 | 2004-04-07 | 中国药科大学 | 治疗呼吸系统疾病的无氟里昂药用气雾剂 |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0323685D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0323684D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| US20060018840A1 (en) | 2004-06-28 | 2006-01-26 | Nektar Therapeutics | Aerosolizable formulation comprising nicotine |
| WO2007020204A2 (en) | 2005-08-12 | 2007-02-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate |
| GB0915106D0 (en) | 2009-08-28 | 2009-10-07 | Glaxo Group Ltd | Process |
| WO2012093252A1 (en) | 2011-01-06 | 2012-07-12 | Cipla Limited | Pharmaceutical composition |
| GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
-
2011
- 2011-05-13 GB GBGB1108039.7A patent/GB201108039D0/en not_active Ceased
-
2012
- 2012-05-11 CA CA2835810A patent/CA2835810C/en active Active
- 2012-05-11 CN CN201280022952.2A patent/CN103517706A/zh active Pending
- 2012-05-11 AU AU2012257546A patent/AU2012257546C1/en active Active
- 2012-05-11 EP EP12727901.6A patent/EP2706987B8/en active Active
- 2012-05-11 ES ES12727901.6T patent/ES2541417T3/es active Active
- 2012-05-11 CN CN201710367505.5A patent/CN107252415B/zh active Active
- 2012-05-11 JP JP2014509839A patent/JP5904613B2/ja active Active
- 2012-05-11 MX MX2013012975A patent/MX340924B/es active IP Right Grant
- 2012-05-11 BR BR112013029202-4A patent/BR112013029202B1/pt active IP Right Grant
- 2012-05-11 WO PCT/GB2012/051059 patent/WO2012156711A1/en active Application Filing
- 2012-05-11 US US14/117,340 patent/US20140234229A1/en not_active Abandoned
-
2013
- 2013-10-30 ZA ZA2013/08208A patent/ZA201308208B/en unknown
-
2016
- 2016-02-09 JP JP2016022722A patent/JP6125679B2/ja active Active
- 2016-08-29 US US15/250,319 patent/US10258568B2/en active Active
- 2016-09-20 US US15/270,519 patent/US10258569B2/en active Active
-
2019
- 2019-01-16 US US16/249,133 patent/US10668018B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190142750A1 (en) | 2019-05-16 |
| US20170007701A1 (en) | 2017-01-12 |
| JP2016138107A (ja) | 2016-08-04 |
| US10258568B2 (en) | 2019-04-16 |
| GB201108039D0 (en) | 2011-06-29 |
| MX340924B (es) | 2016-08-01 |
| US20170027867A1 (en) | 2017-02-02 |
| CN103517706A (zh) | 2014-01-15 |
| US10668018B2 (en) | 2020-06-02 |
| JP2014513146A (ja) | 2014-05-29 |
| CA2835810A1 (en) | 2012-11-22 |
| EP2706987B1 (en) | 2015-04-08 |
| ZA201308208B (en) | 2014-06-25 |
| BR112013029202B1 (pt) | 2022-04-12 |
| US10258569B2 (en) | 2019-04-16 |
| EP2706987B8 (en) | 2015-05-27 |
| AU2012257546C1 (en) | 2015-12-24 |
| CA2835810C (en) | 2016-08-09 |
| US20140234229A1 (en) | 2014-08-21 |
| CN107252415B (zh) | 2020-08-11 |
| CN107252415A (zh) | 2017-10-17 |
| EP2706987A1 (en) | 2014-03-19 |
| AU2012257546B2 (en) | 2015-06-18 |
| WO2012156711A1 (en) | 2012-11-22 |
| ES2541417T3 (es) | 2015-07-20 |
| JP5904613B2 (ja) | 2016-04-13 |
| AU2012257546A1 (en) | 2013-11-28 |
| JP6125679B2 (ja) | 2017-05-10 |
| MX2013012975A (es) | 2013-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013029202A2 (pt) | solução farmacêutica, recipiente selado, inalador de dose medida, método para tratar um paciente que sofre ou que está susceptível a sofrer de um distúrbio respiratório, usos de um propelente, de uma composição farmacêutica, e, de um aparelho de administração de medicamentos que contém uma composição farmacêutica | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| BR112014008852A2 (pt) | aplicador portátil para auto-administração direcionada de um medicamento semi-sólido diretamente ao couro cabeludo, sistema de disponibilização de preparações semi-sólidas, cartucho para armazenar um reservatório de medicamento, sistema de aplicador para uso na aplicação de medicamento a um paciente e método para disponibilizar medicamento semi-sólido para couro cabeludo ou outra área do corpo | |
| IL232308A (en) | Compounds as modulators of atp-linked casting, pharmaceuticals containing them and their use in the preparation of drugs for the treatment of diseases and processes for their preparation | |
| UA115139C2 (uk) | Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту | |
| PH12014501461A1 (en) | Inhalation device and method | |
| GB201210580D0 (en) | Metered dose dispensing valve | |
| BR112014008609A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica | |
| WO2012052853A3 (en) | Oral dosing device for administration of medication | |
| BR112014008602A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica | |
| BR112013002504A2 (pt) | formulação farmacêutica para administração em aerosol, inalador pressurizado dosimetrado (pmdi), formulação farmacêutica para nebulização, frasco de dose única ou múltiplas e uso de uma formulação | |
| TWI561260B (en) | Dose unit, pack of dose units and inhaler for inhalation of combination of drugs | |
| HK1208830A1 (en) | Drug delivery device for the treatment of patients with respiratory diseases | |
| MX2022009231A (es) | Inhalador de polvo seco y metodo de uso. | |
| EA201491281A1 (ru) | КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ | |
| BR112012000862A8 (pt) | composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento | |
| BRPI1007732A2 (pt) | aparelho para administração de medicamentos para a administração de um aerossol incluindo um medicamento para um paciente, kit para a administração de um aerossol incluindo um medicamento para um paciente e método de administração de um aerossol incluindo um medicamento para um paciente | |
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| MD20140131A2 (ro) | Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu | |
| CY1117596T1 (el) | Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης | |
| BR112015018121A2 (pt) | composição para terapia por inalação, composição farmacêutica, inalador de pó seco, inalador pressurizado dosimetrado ou inalador nasal ativado por respiração, método de tratar uma doença ou distúrbio respiratório ou uma doença ou distúrbio pulmonar em um paciente, e, método de preparar composições ou inaladores | |
| WO2011037549A3 (en) | Dry powder formulation of tiotropium carried in blister strip | |
| ES2422563A1 (es) | Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma | |
| EP2684566A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF DIABETES COMPLICATIONS CONTAINING A TRADITIONAL ORIENTAL MEDICINAL EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT | |
| TR200907238A2 (tr) | Tiotropyum içeren kombinasyonun blisterde taşınması. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/05/2012, OBSERVADAS AS CONDICOES LEGAIS. |